Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

Social determinants of health, such as neighborhood disadvantage, have been linked to an increased risk of clinical dementia syndrome; however, their association with neuropathologically confirmed Alzheimer's disease (AD) remains unknown. This is a critical gap because US neighborhood disadvantage is measureable, potentially modifiable and can be targeted specifically for research recruitment and intervention. The objective of this study was to employ geoanalytic techniques to investigate the association between neighborhood disadvantage and neuropathologically confirmed AD cases in two Alzheimer's Disease Research Center (ADRC) brain banks. The study included all brain bank participants with an available non-institutional address at the time of death (N=434; Figure 1). Addresses were geocoded, then linked to a corresponding Area Deprivation Index (ADI) state ranking, a validated measure of US neighborhood disadvantage which incorporates poverty, education, housing, and employment indicators. All neuropathological data were collected via NACC methodologies, using neuritic and diffuse plaque presence on neuropathological exam to determine AD. Results were analyzed utilizing basic frequencies and multinomial logistic regression, adjusting for age and sex, comparing those residing in the most disadvantaged 20% of neighborhoods to those in the least disadvantaged 80% of neighborhoods-- a standard approach for neighborhood disadvantage studies. There was no significant difference in mean age or proportion of male participants between those in the most disadvantaged 20% of neighborhoods to those in the least disadvantaged 80% of neighborhoods. However, significant differences were found in amyloid plaque burden, whereby the more disadvantaged group had a higher proportion of both neuritic and diffuse plaques. (Table 1) As compared to those from the least disadvantaged neighborhoods, participants from the most disadvantaged neighborhoods had higher adjusted odds of neuropathologically confirmed AD (Adjusted OR=5.24, [95% CI: 1.12, 20.09], p=0.034).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Larson, J. L., Rissman, R. A., Vilen, L. H., Melah, K. E., Loosen, J. A., Salamat, S. M., et al. (2019). P2‐435: NEIGHBORHOOD DISADVANTAGE IS ASSOCIATED WITH NEUROPATHOLOGICALLY CONFIRMED ALZHEIMER'S DISEASE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2019.06.2842

Vancouver

Larson JL, Rissman RA, Vilen LH, Melah KE, Loosen JA, Salamat SM, et al. P2‐435: NEIGHBORHOOD DISADVANTAGE IS ASSOCIATED WITH NEUROPATHOLOGICALLY CONFIRMED ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 2019. doi:10.1016/j.jalz.2019.06.2842.

BibTeX

@article{larson2019-f458b5ba,
  author  = {Larson, Jamie L. and Rissman, Robert A. and Vilen, Leigha H. and Melah, Kelsey E. and Loosen, Julia A. and Salamat, Shahriar M. and Roy, Subhojit and Asthana, Sanjay and others},
  title   = {{P2‐435: NEIGHBORHOOD DISADVANTAGE IS ASSOCIATED WITH NEUROPATHOLOGICALLY CONFIRMED ALZHEIMER'S DISEASE}},
  journal = {Alzheimer s \& Dementia},
  year    = {2019},
  doi     = {10.1016/j.jalz.2019.06.2842},
  url     = {https://doi.org/10.1016/j.jalz.2019.06.2842}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This study examined whether neighborhood disadvantage is linked to neuropathologically confirmed Alzheimer's disease in 434 brain bank participants. It used the Area Deprivation Index, a measure incorporating poverty, education, housing and employment indicators, to compare those in the most disadvantaged 20% of neighborhoods to those in the least disadvantaged 80%.

Study details

How this study scored 38/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 2 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 38 of 100.38 of 100 points earned62 not earned

Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2019 — within 10 year(s) of the newest study here
Sample size 2 / 4 434 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.1 citations a year over 9 year(s) since 2019
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Amy Kind: h-index 47 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California San Diego: institution h-index 1,852 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 38 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Related studies in Risk factors

Also in Risk factors

356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.

Similar studies

More on Risk factors

See all studies in Risk factors →